Castle Biosciences CSTL Balance Sheet (2018-2026)

NASDAQ CSTL
$33.79 -0.71 (-2.06%)
At close: Nov 13, 2026 · 4:00 PM EST
Reported Financials

Castle Biosciences Quarterly Balance Sheet

Periods 34 quarters
Latest Sep 2026

Castle Biosciences reported total assets of $579.41M and total liabilities of $100.96M for the quarter ended Sep 2026, up 3.0% year over year. This balance sheet covers 34 quarters of results from Jun 2018 through Sep 2026, standardized by Business Quant from the company’s SEC filings.

Balance SheetBalance Sheet Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026 Sep2026
Assets
Current Assets
Cash & EquivalentsCash & Equiv.
329.63M309.02M273.17M134.18M122.95M114.82M95.90M91.22M98.84M82.95M85.60M95.00M119.71M89.70M82.23M85.60M116.73M63.80M62.12M78.00M
Short-term InvestmentsInvestments (Current)
131.80M135.68M117.23M129.63M138.53M144.26M156.30M174.12M184.83M173.42M185.50M193.70M202.00M182.78M197.92M204.70M199.70M
Cash & Current Investments
329.63M309.02M273.17M265.98M258.63M232.06M225.53M229.75M243.10M239.25M259.72M279.83M293.13M275.20M275.93M287.60M299.51M261.72M266.82M277.70M
Receivables - NetNet Receivables
17.28M19.91M22.61M22.84M23.48M27.73M31.31M37.00M38.30M42.70M45.99M50.26M51.22M56.35M52.31M49.48M43.38M42.26M48.34M52.10M
Receivables
17.28M19.91M22.61M22.84M23.48M27.73M31.31M37.00M38.30M42.70M45.99M50.26M51.22M56.35M52.31M49.48M43.38M42.26M48.34M52.10M
Inventory
2.02M2.35M3.37M3.80M3.98M4.52M6.12M5.77M7.94M7.65M8.01M6.57M8.14M6.85M8.37M8.65M10.25M10.46M10.58M10.38M
Prepaid Assets
4.81M5.16M5.78M6.80M6.21M6.80M6.11M7.10M6.29M6.22M6.72M8.15M7.67M11.04M12.06M11.90M7.96M14.49M15.37M16.71M
Current Assets
353.74M336.44M304.91M299.41M292.29M271.10M269.05M279.62M295.64M295.78M320.41M344.77M360.15M349.39M348.67M357.57M361.10M328.90M341.10M356.86M
Non-Current Assets
Property, Plant & Equipment (Net)PP&E (Net)
9.50M9.39M11.20M13.05M14.32M18.25M20.51M22.27M25.43M32.90M38.64M44.38M51.12M55.42M74.06M84.89M97.44M100.93M104.68M111.46M
Long-Term Investments
-0.18M-1.37M-1.23M-2.28M-3.85M-5.49M-1.70M-3.42M-5.07M5.57M-2.61M-3.51M
Goodwill
10.49M10.49M10.70M10.70M10.70M10.70M10.70M10.70M10.70M10.70M10.70M10.70M10.70M10.70M10.70M10.70M10.70M10.70M
Intangibles
88.92M87.28M
Goodwill & Intangibles
88.92M87.28M132.67M130.36M126.35M124.13M121.88M119.61M117.34M115.09M112.84M110.57M106.23M77.90M104.13M101.85M99.57M97.35M95.10M91.49M
Other Non-Current Assets
1.72M2.70M1.22M1.20M1.11M0.79M1.19M1.57M1.44M1.72M2.68M1.83M1.23M1.27M1.24M1.28M3.77M4.28M4.44M4.36M
Non-Current Assets
108.83M107.98M153.47M158.40M155.04M155.79M156.35M156.40M157.71M162.73M166.91M169.79M171.08M152.33M196.06M205.22M217.46M218.90M220.08M222.55M
Assets
462.57M444.43M458.38M457.81M447.33M426.89M425.40M436.02M453.34M458.51M487.31M514.57M531.24M501.72M544.73M562.79M578.56M547.81M561.18M579.41M
Liabilities
Current Liabilities
Accounts Payables
2.55M3.31M3.28M5.77M4.73M9.96M7.14M6.93M10.27M9.32M9.54M6.81M6.90M8.50M13.18M12.21M18.71M15.04M9.67M13.23M
Notes Payables
Payables
2.55M3.31M3.28M5.77M4.73M9.96M7.14M6.93M10.27M9.32M9.54M6.81M6.90M8.50M13.18M12.21M18.71M15.04M9.67M13.23M
Other Accumulated Expenses
5.68M5.59M8.18M5.11M5.26M5.61M7.32M5.90M7.32M6.74M7.45M8.07M7.99M8.37M8.22M8.89M8.94M10.69M14.11M15.18M
Short term Debt
0.28M1.11M1.94M0.42M1.67M2.92M4.17M
Current Deferred Revenue
Total Current Liabilities
24.89M39.52M27.52M31.94M36.13M30.14M33.72M36.32M47.67M31.96M39.45M44.30M49.39M37.27M50.89M55.31M68.68M48.76M56.51M67.61M
Non-Current Liabilities
Capital Leases
0.03M0.31M0.29M0.31M0.33M0.36M0.34M0.31M0.29M0.26M0.24M
Non-Current Debt
10.00M10.01M10.02M9.75M8.92M8.10M10.05M9.64M8.40M7.16M5.92M
Non-Current Deferred Revenue
Preferred Stock Liabilities
Non-Current Deferred Tax LiabilityNon-Current Deferred Tax
0.64M0.76M0.61M0.61M0.43M0.44M0.44M0.44M0.21M0.21M4.22M1.61M0.84M3.13M3.24M2.34M2.33M2.32M2.40M
Operating Leases
6.90M6.71M6.48M11.90M11.53M11.10M12.43M13.44M14.17M13.86M13.65M14.69M14.35M14.05M25.38M25.30M25.22M25.12M24.89M24.61M
Other Non-Current Liabilities
36.70M0.10M2.11M1.92M0.09M0.06M0.05M0.04M0.02M2.50M4.00M1.50M1.50M0.19M
Total Non-Current Liabilities
14.13M46.99M34.61M44.46M48.09M41.69M46.59M50.20M62.07M56.03M63.42M73.51M75.40M86.85M91.74M106.18M84.89M91.15M100.77M
Total Liabilities
50.83M47.09M36.72M46.38M48.18M41.74M46.63M50.24M62.07M56.05M63.42M73.51M75.40M61.41M89.35M95.74M107.68M86.39M91.15M100.96M
Shareholder's Equity
Total Debt
10.00M10.01M10.02M10.02M10.03M10.04M10.05M10.06M10.07M10.08M10.08M
Common Equity
411.74M397.34M421.66M411.43M399.15M385.15M378.77M385.78M391.27M402.46M423.89M441.06M455.84M440.31M455.38M467.05M470.87M461.42M470.03M478.44M
Liabilities and Shareholders Equity
462.57M444.43M458.38M457.81M447.33M426.89M425.40M436.02M453.34M458.51M487.31M514.57M531.24M501.72M544.73M562.79M578.56M547.81M561.18M579.41M
Retained Earnings
-93.77M-118.39M-120.04M-140.29M-160.91M-190.11M-208.90M-215.80M-218.37M-220.91M-212.00M-209.72M-200.13M-226.00M-221.50M-222.00M-224.28M-238.81M-240.90M-245.00M

Castle Biosciences Balance Sheet API

Pull Castle Biosciences's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=CSTL&statement=BS&frequency=Quarter&period=all&api_key=YOUR_API_KEY